Insilico Medicine’s drug discovery system consists of three main pipelines: target discovery, small molecule drug discovery, and predictors of clinical trial outcomes. This system is designed to achieve maximum automation of drug discovery processes for abroad range of human diseases. Since there is a known protease target for 2019-nCoV and its sequence and structure are known, Insilico Team decided to apply only the generative chemistry pipeline to generate the possible drug-like hits.
Damo accademy has developed a cloud based AI for covid diagnostic. The algorithm has been trained on the data of more than 5000 subjects affected by COVID-19, and now can analyse a TAC exam in only 15 seconds discriminating coronavirus cases from a normal pneumonia ones with 96% of success. Therefore, its application could potentially reduce the time to recognize and treat patients affected by the COVID-19.
Istituto di Robotica e Macchine Intelligenti | Largo Lazzarino, 1 - Pisa | C.F. 93092770507
Ente iscritto alla sezione "ALTRI ENTI DEL TERZO SETTORE", del registro unico nazionale del Terzo Settore, ai sensi dell'arti. 22 del D. Lgs. del 3 luglio 2017 n.117 e dell'art. 17 Decreto Ministeriale n. 106 del 15/09/2020. Data certificazione ss.m:04/01/2023